Recursion Pharmaceuticals (RXRX) has drawn attention after recent trading, with the share price closing at US$3.42 and short term returns showing pressure over the past week, month and past 3 months.

Factorial has rolled out a striking out-of-home activation in Paris, transforming the promise of AI-powered efficiency into a tangible, real-world experience. Conceptualised by creative agency ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Billerica battery startup ...

The two companies agreed to cooperate in the development of all-solid-state battery materials. In sample testing of materials from multiple suppliers, POSCO Future M demonstrated good rate capability.

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Recursion Pharmaceuticals is known for its Recursion Operating System (Recursion OS), a full-stack platform that uses artificial intelligence (AI), automation, and massive biological datasets to ...

AI drug discovery specialist Recursion Pharmaceuticals is shelving three of its most advanced drug prospects in an effort to cut costs following a merger last year. Alongside its latest quarterly ...

I'm diving deep into the intersection of infrastructure and machine learning. I'm fascinated by exploring scalable architectures, MLOps, and the latest advancements in AI-driven systems ...

In a significant leap for electric vehicle technology, Mercedes-Benz has embarked on road tests of an EQS sedan outfitted with a pioneering lithium-metal solid-state battery. This initiative, launched ...